Initial experience with a new distal intermediate and aspiration catheter in the treatment of acute XXXX : clinical safety and efficacy.

@entity1 @entity64 @entity1031 @entity715 @entity385
PURPOSE: To describe our initial experience with the novel 5   F SOFIA (Soft Torqueable catheter Optimized For Intracranial Access) intermediate and aspiration catheter for endovascular treatment of @entity1 with acute @entity385 . METHODS: A retrospective review was performed in three centers of prospectively collected data of all @entity64 @entity1 who underwent endovascular therapy using the SOFIA catheter. @entity1 were enrolled between November 2013 and December 2014. The primary endpoint of the study was accessibility of the @entity715 with the SOFIA catheter. As a secondary endpoint, the study assessed recanalization success ( @entity385 ( @entity385 ) >= 2b). Clinical presentation on admission and discharge was also documented. In addition, catheter- and procedure-related complications (particularly @entity1031 complications) were recorded. RESULTS: The SOFIA catheter was used in 115 @entity64 . In 110 cases (96%) the catheter could be advanced to the occlusion site. After mechanical thrombectomy, successful recanalization ( @entity385 >= 2b) was documented in 86.9%. There were no complications related to positioning of the catheter. Distal @entity715 migration into a new vascular territory occurred in three @entity1 following thrombectomy with a stent retriever (2.6%). The mean NIH @entity64 Scale (NIHSS) score on admission was 16.8  6 and at discharge the mean NIHSS score was 8.2  7.7. Sixteen @entity1 died. CONCLUSIONS: The SOFIA catheter is a safe and efficient catheter for @entity64 therapy.
